Form D — RenaBio Therapeutics, Inc.
0002018021-25-000001 · filed 2025-02-26
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $4,193,670
- Total sold
- $250,000
- Minimum investment
- $5,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- RenaBio Therapeutics, Inc.
- CIK
- 2018021
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 22 STRATHMORE RD, #353
NATICK, MA 01760 - Phone
- (617) 721-0785
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Shengjun Ren · Executive OfficerNatick, MA Find on LinkedIn ↗
-
Jafari Mousa · DirectorNatick, MA Find on LinkedIn ↗
-
Yu (Zoe) Zhang · DirectorNatick, MA Find on LinkedIn ↗
-
Zhenghua Wang · DirectorNatick, MA Find on LinkedIn ↗
-
Hans Bitter · DirectorNatick, MA Find on LinkedIn ↗
View original on SEC EDGAR.